Status:
ENROLLING_BY_INVITATION
Developing Derived Induced Pluripotent Stem Cells as a Model to Understand Imprinted Disorders
Lead Sponsor:
Institute of Cardiometabolism and Nutrition, France
Conditions:
Induced Pluripotent Stem Cells
Eligibility:
All Genders
3+ years
Brief Summary
Fetal and postnatal growth is finely regulated by genetic, epigenetic and environmental mechanisms. Parental imprinting is a regulatory mechanism that allows monoallelic expression of certain genes fr...
Eligibility Criteria
Inclusion
- Minor or young adult patients treated in the department, suffering from rare growth diseases: Silver-Russell syndrome (SRS), Beckwith-Wiedemann syndrome (BWS) and Temple syndrome (TS)
- For minors, the patient's weight must be ≥ 5 kg
Exclusion
- Patients unable to express their opposition to the use of their personal data.
Key Trial Info
Start Date :
January 19 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT05214742
Start Date
January 19 2022
End Date
December 1 2026
Last Update
April 28 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Trousseau
Paris, France, 75012